ARL67156 triethylamine||(FPL 67156 triethylamine)-陌孚医药/Medlife

您当前的位置：

ARL67156 triethylamine (Synonyms: FPL 67156 triethylamine)

目录号: PL09555 纯度: ≥98.0%

商品编号	规格	价格	会员价
PL09555-1mg	1mg	¥2225.45	请登录
PL09555-5mg	5mg	¥8036.36	请登录
PL09555-10mg	10mg	¥12858.18	请登录
PL09555-50mg	50mg	询价	询价
PL09555-100mg	100mg	询价	询价

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	ARL67156 triethylamine
英文名称	ARL67156 triethylamine
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情	ARL67156 (FPL 67156) triethylamine 是一种 ecto-ATPase 抑制剂。ARL67156 triethylamine 是竞争性 NTPDase1 (CD39)，NTPDase3 和 NPP1 抑制剂，K_i 分别为 11，18 和 12 μM。ARL67156 triethylamine 可用于钙化性主动脉瓣疾病、哮喘等疾病的研究。
生物活性	ARL67156 (FPL 67156) triethylamine is a selective ecto-ATPase inhibitor. ARL67156 triethylamine is a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with K i s of 11, 18 and 12?μM, respectively. ARL67156 triethylamine can be used in the research of disease like calcific aortic valve disease, asthma.
性状	Solid
IC50 & Target[1][2]	Ki: 11 μM (NTPDase1), 18 μM (NTPDase3), 12 μM (NPP1)
体外研究(In Vitro)	ARL67156 triethylamine (1-100 μM) potentiates neurogenic contractions in a concentration-dependent manner. ARL67156 triethylamine (10 μg/mL, 24 h) increases the surface expression of CXCR3 on ATP-treated HMC-1 cells. ARL67156 triethylamine (30 μM, 5s) potentiates the norepinephrine release promoted by ATP in guinea pig heart synaptosomes. ARL67156 triethylamine (100 μM, 4h) significantly decreases HIV-1replication in macrophages. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	ARL67156 triethylamine (1.1 μg/kg/day, administered with osmotic pumps implanted subcutaneously, for 28 days) prevents the development of calcific aortic valve disease in Warfarin (HY-B0687)-treated rats. ARL67156 triethylamine (intraperitoneal injection, 2?mg/kg) prevents the increase of serum adenosine concentration induced by Fructose 1,6-bisphosphate (FBP). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. évesque SA, et al. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol. 2007 Sep;152(1):141-50. [2]. Nancy C?té, et al. Inhibition of Ectonucleotidase With ARL67156 Prevents the Development of Calcific Aortic Valve Disease in Warfarin-Treated Rats. Eur J Pharmacol. 2012 Aug 15;689(1-3):139-46.

溶解度数据	In Vitro: Methanol : 125 mg/mL (108.30 mM; Need ultrasonic)DMSO : 100 mg/mL (86.64 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation